Early Development...

8/17/2009 BioSante Reports 100% Protection From H1N1 Challenge Using BioVant

11/17/2008 BioSante Announces receipt of NIH Grant for Inhaled Interferon

11/19/2007 BioSante Pharmaceuticals Announces License Agreement for its CaP Technology in Aesthetic Medicine

8/27/2007 BioSante Pharmaceuticals Presents Flu Vaccine Data at Novel Vaccines Conference

3/22/2006 BioSante Pharmaceuticals Presents New Anthrax Vaccine Data at World Vaccine Congress

Web Hosting powered by Network Solutions®